London-based investment fund Plural has launched a new €400m ($485m) fund to back early-stage tech start-ups. Plural, which was founded in 2022, invests in companies across Europe and the US that tackle global challenges using technology. The fund’s investor team comprises individuals who have spearheaded significant tech firms such as Skype and Wise. Since its launch, Plural has invested in 26 companies in six countries, focusing on sectors including artificial intelligence, climate and energy, and frontier technology.
Plural: Empowering London Founders with €400 million Investment Boost
Latest from Blog
Antheia Secures $17M Investment
TLDR: Antheia, a pharmaceutical ingredient manufacturer based in Menlo Park, CA, raised $17M in funding. The funding included a non-dilutive two-year project agreement up to $11M through the BioMaP Consortium. Antheia, led
GRO Biosciences Secures $603M in Series B Funding
TLDR: GRO Biosciences, a biotechnology company, raised $60.3M in Series B funding led by Atlas Venture and Access Biotechnology. The company plans to use the funds to advance its lead program for
Raising $250 Million: North Sky Capital’s Impact Secondaries Fund
TLDR: North Sky Capital raised $250 million for its impact secondaries fund, Clean Growth VI. The fund aims to generate strong private equity returns while creating positive environmental and social benefits. North
Aven Achieves Unicorn Status: Raises $142m in Series D
TLDR: Aven, a fintech company offering home equity-backed credit cards, reaches unicorn status with a US$142m Series D funding round led by Khosla Ventures and General Catalyst. Founded in 2019 by former
Cell BioEngines Secures $2M Funding from SOSV and NY Ventures
TLDR: Cell BioEngines, Inc. secures an additional $2 million in funding from SOSV and Empire State Development’s New York Ventures. The funding will support the company’s first multicenter clinical trial aimed at